Read this first
Conclusion of this page
Verify the medication name, current dose, injection day, and the date of the most recent dose increase, and do not apply the missed dose rules of other medications.
More important safety questions are whether you can maintain hydration, if your urine output has decreased, or if severe abdominal pain persists, rather than just nausea.
Pregnancy plans, contraceptives, diabetes medications, and schedules for surgery, endoscopy, or anesthesia must be disclosed to both the person prescribing the injection and the relevant medical staff.
If you do not know the name, ingredients, and dosage of your medication, you may apply incorrect information even if it is categorized as 'weight loss medicine.' This page does not replace individual prescription changes or emergency medical care.
First, check the product on the pen and prescription
Wegovy, Mounjaro, and others are all called 'diet injections,' but their ingredients, concentrations, dosage increase stages, and rules for missed doses differ. Please write down the name of the medication on the pen, current dose, administration day, last administration date, and the most recent date of dose increase.
Even if pens or vials look similar, their units and usage methods may not be the same. Do not use products with unclear labels, products where the official prescription or dispensing route is difficult to verify, or powders and vials obtained from the internet that have been arbitrarily diluted. Confusion regarding concentration and units can lead to overdose.
What should be compared besides weight when choosing injection therapy?
Beyond the convenience of administration, such as once-weekly dosing, and expected weight loss, we consider whether you can tolerate nauseaconstipationand whether you can maintain water and food intake, if you use diabetes medication concurrently, and if you can accurately perform the injection and storage. Travel, shift work, and the ability to store the medication in a refrigerator also affect actual adherence.
When comparing with oral medications or Korean herbal medicine, do not simply place weight loss figures from different studies side-by-side. The target population, duration, lifestyle management, discontinuation rates, side effects, and comorbidities differ. First, determine the benefits that are important to you and the discomforts you wish to avoid with your medical provider.
What medical history and medications should be disclosed before starting?
Please disclose diabetes and current blood sugarhypoglycemic agents,insulinexperiences of hypoglycemia, gallbladder, pancreatic, or kidney diseases, severe gastrointestinal motility disorders, diabetes-related eye complications, and whether you are planning pregnancy, pregnant, or breastfeeding. Depending on the product, specific thyroid-related history or family history may be included as contraindications or precautions, so the approved information of the corresponding productof the corresponding product.
Please also disclose the use of other weight control medications, Korean herbal medicine, supplements, and any state where you have been unable to drink fluids due to recent vomiting or diarrhea. If sedation or anesthesia is scheduled for surgery, endoscopy, or dental procedures, provide the product name and last administration date to the procedure team.
What should be recorded before the first dose and before increasing the dose?
Before administration, record your usual bowel movements, nausea, abdominal pain, fluid and food intake, urine output, and blood glucose. Before increasing the dose, verify with your prescriber whether there was vomiting, abdominal pain, or constipation during the previous stage, and whether food and water intake were maintained.
Do not move the schedule forward just because there are no symptoms. Gradual dose increase is a process to verify not only efficacy but also whether the body can tolerate it. When restarting after a break in medication, do not return immediately to the previous maximum dose; verify the appropriate method based on the duration of the interruption.
What should be monitored at home when nausea occurs?
Eat slowly in small amounts rather than eating a lot at once, and if not restricted by your prescriber, drink water in small sips. Greasy foods and excessive drinking may increase discomfort. However, these dietary tips are not a substitute for a medical evaluation.
Rather than just nausea, monitor the frequency of vomiting, whether you can keep fluids down, if urine output has decreased, or if you feel severely dizzy when standing up. If these situations are related to the medical evaluation or intake of Baekrok Gambi-jeong, repeated vomiting or dehydration such signals should be reported to Baekrokdam on the same day before the next dose, and you should follow the provided guidance.
Why should I not wait when experiencing severe abdominal pain?
If you experience persistent severe upper abdominal pain, pain radiating to the back, repeated vomiting, fever, or jaundice, the cause, such as the gallbladder or pancreas, must be identified. Do not rely solely on painkillers or wait until your next injection date.
Please provide the location and start time of the pain, the date of the last dose, and whether you have vomiting, fever, or jaundice. If you experience swelling of the face or tongue, difficulty breathing, or generalized hives, it may be an allergic emergency; use 119 or an emergency medical institution immediately.
What changes when used with diabetes medication?
The risk of hypoglycemia differs between using some injectables alone versus using them in combination with insulin or specific glucose-lowering agents. If you experience tremors, cold sweats, severe hunger, dizziness, or confusion, check your blood glucose if possible and follow the hypoglycemia management guidelines you received.
If consciousness is clouded or swallowing is difficult, do not force food and seek help immediately. Changes in weight and intake may require adjustments to existing diabetes medication, but do not decrease or increase the dose on your own.
When should I discuss pregnancy plans and contraception?
Before starting the prescription, inform your provider about the possibility of pregnancy, your timing for planning, and your method of contraception. GLP-1 This class of medication and related drugs should not be used during pregnancy, and the required discontinuation period before pregnancy may vary by product. Some products, such as Tirzepatide, may have separate guidance regarding oral contraceptives, so you must check the product's approved indications and the medical staff's instructions.
If you find out you are pregnant or if your plans change, contact your prescriber immediately rather than waiting for your next appointment. If you have diabetes, your blood glucose treatment may need to be changed accordingly, so avoid arbitrarily stopping or restarting medication.
What information should I check if I missed an injection date?
Check the medication name, the originally scheduled date, the date of the last dose, and the time remaining until the next scheduled dose. Since the allowable window varies by medication, do not apply the rules of a different injection or administer two doses at once.
If you have missed multiple doses or have paused treatment for a long time, ask the prescribing institution about the restart steps. Returning immediately to the previous dose may increase gastrointestinal symptoms.
Commonly overlooked points in storage and pen usage
Refrigeration requirements, allowable room temperature periods, and precautions regarding light and freezing vary by product. Do not arbitrarily use pens that may have frozen or overheated, liquids showing discoloration or particles, or products past their expiration date; verify them with the pharmacy or prescribing institution.
Do not reuse needles or share pens with others. When traveling, prepare the storage conditions and needle disposal methods specific to the product in advance. Do not unofficially calculate the dose based solely on the 'number of clicks' of the pen.
What should I communicate before surgery, endoscopy, or anesthesia?
Inform both the procedure team and the injection prescriber of the medication name, dose, last dose date, and any recent nausea, vomiting, or bloating. Fasting and anesthesia plans may be adjusted due to the possibility of delayed gastric emptying.
Do not arbitrarily apply a general discontinuation period found on the internet. The decision varies based on the type of procedure, whether it is an emergency, diabetes control, and the specific product.
During a follow-up visit while taking the medication, what is monitored besides weight?
waist circumferenceand blood glucose·blood pressure, food and fluid intake, muscle strength and activity, vomiting, constipation, abdominal pain, sleep and mood, and changes in other medications are all considered. Even if weight decreases, treatment adjustment may be necessary if you cannot drink water or if muscle strength declines.
Determine the first evaluation date, conditions for the next dose increase, and criteria for discontinuation or modification with your prescriber. If the effect is insufficient or side effects make daily life difficult, discuss goals and treatment alternatives again rather than pushing for a dose increase.
If you are considering Korean herbal medicine as an alternative or combination therapy
Do not immediately add diet-related Korean herbal medicine as a 'recovery' aid or arbitrarily stop injections just because you have injection side effects. The cause must be evaluated based on your current injections, symptoms, diabetes medication, and test results before determining the possibility of switching or combining treatments.
At Baekrokdam, after reviewing your injection history, last administration date, gastrointestinal symptoms, sleep, diet, and concomitant medications, we will advise whether tablet-form Korean herbal medicine, such as Baekrok Gambi-jeong, is an option or if a visit to your original prescribing institution for an in-person evaluation is required first.
Integrated Customer Questions
Questions previously scattered across various posts are answered here
We have gathered questions that require the same judgment, even if expressed differently, into this guide.
If I am worried about muscle loss during GLP-1 treatment, can I switch to Korean herbal medicine?
Do not arbitrarily discontinue current treatment or automatically replace it with Korean herbal medicine based solely on concerns about muscle loss. Compare treatment directions with your prescribing medical staff after reviewing the rate of weight loss, intake, protein and resistance exercise, changes in body composition, and side effects.
If I feel stomach discomfort after using GLP-1, can I start Korean herbal medicine at the same time?
Persistent vomiting, abdominal pain, or dehydration must first be evaluated for side effects of the current treatment or other causes. Do not arbitrarily add other treatments to mask discomfort; instead, inform your medical staff of the product, dose, last administration, and the timeline of your symptoms.
Can using Korean herbal medicine after stopping GLP-1 prevent the yo-yo effect?
No treatment can guarantee that it will automatically prevent weight regain after discontinuation. First, organize your appetite, intake, sleep, activity, weekly weight trends, and the reason for discontinuation, then establish a medical plan that allows for long-term maintenance.
Verification of Evidence
What the evidence says and what it cannot say
Current obesity clinical guidelines recommend selecting and monitoring pharmacological treatments, including injections, in conjunction with an individual's comorbidities, preferences, and responses.
- Meaning in My Situation
- You must compare not only the average weight loss but also the burden of injections, gastrointestinal symptoms, diabetes medication, and the possibility of follow-up.
- Limitations of Interpretation
- Average results from guidelines cannot predict an individual's specific weight loss or side effects.
Product approval details provide specific warnings for each product regarding gradual dose increases, gastrointestinal adverse reactions, and issues related to the gallbladder, pancreas, kidneys, and allergies.
- Meaning in My Situation
- Do not accelerate dose increases; persistent abdominal pain, repeated vomiting, or decreased urination must be evaluated before the next dose.
- Limitations of Interpretation
- Dosage, missed doses, and contraindications for semaglutide and tirzepatide cannot be applied interchangeably.
MHRA patient guidance separately emphasizes the latest safety issues such as pregnancy, contraception, surgery, the use of genuine products, and acute pancreatitis.
- Meaning in My Situation
- Please let us know if you are preparing for pregnancy or have an upcoming surgery. This is necessary when determining when to start or stop injections.
- Limitations of Interpretation
- As this is guidance from a UK regulatory agency, you must also check domestic prescriptions, approval details, and instructions from your attending medical staff.
During medical evaluation
How will this information be verified during a medical evaluation?
Individual prescriptions cannot be determined by public guides alone. During a medical evaluation, the name and dosage of medications being taken, medical history, and current symptoms are verified together.
Medical professional who reviewed this text
Choi Yeon-seung
Chief Director of Baekrokdam Korean Medicine ClinicWe have reviewed the product and dose increase verification, as well as safety actions related to gastrointestinal issues, dehydration, hypoglycemia, pregnancy, and surgery for weight control injections. During the consultation, we will verify your actual prescription, administration time, and current symptoms to determine the next steps together.
- Graduated from Kyung Hee University College of Korean Medicine
- Practicing Korean medicine since 2010
- Specializing in constitution improvement and weight loss herbal medicine
- Information Prepared by
- Baekrokdam Korean Medicine Clinic
- Content Reviewed by
- Dr. Choi Yeon-seung, KMD
- Review Scope
- Product and dose increase verification, and safety actions related to gastrointestinal issues, dehydration, hypoglycemia, pregnancy, and surgery for weight control injections
- Last Reviewed
- August 23, 2026
Medical information may be updated. Please prioritize the prescription, medication guide, and instructions provided by your attending medical staff.
Questions
Frequently Asked Questions
If I feel nauseous, does it mean the injection is working well?
Nausea is not an indicator of effectiveness. For safety assessments, it is more important to determine if it interferes with eating and hydration, or if there is repeated vomiting, decreased urination, or persistent abdominal pain.
Can I move up the dose increase schedule because I want to lose weight faster?
No. The dose increase schedule for each product is determined based on tolerability and adverse reactions. Do not move up the schedule or follow another person's dosage without the instructions of your prescriber.
I missed my injection date; can I take it right away?
The criteria for handling missed doses vary by product. Check the medication name, the original scheduled date, and the date of your last dose, then follow the product insert or the guidance of the prescribing institution or pharmacist. Do not administer two doses at once.
Should I inform the medical staff that I am taking injections before an endoscopy or surgery?
Yes. Since it can affect gastric emptying and anesthesia or sedation plans, inform the procedure team and your prescriber of the medication name, dose, and the date of your last dose in advance. The medical staff will decide whether and when to discontinue the medication.
What should I do if I am preparing for pregnancy or taking contraceptive pills?
The required discontinuation period before pregnancy and precautions regarding contraception vary by product. Inform your prescriber of any possibility or plans for pregnancy and your method of contraception, and create a plan according to the approved product specifications. Do not discontinue or resume the medication arbitrarily.
Source
Supporting Evidence
- 2024 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea ↗
Confirmed the targets for obesity pharmacotherapy including injectables, as well as the principles for personalization and tracking effectiveness and adverse reactions.
- WEGOVY (semaglutide) prescribing information ↗
Confirmed dose increases, missed doses, and serious adverse reactions for semaglutide products at the product level.
- ZEPBOUND (tirzepatide) prescribing information ↗
Used administration, contraindications, hypoglycemia, and gastrointestinal safety information for tirzepatide products to distinguish them from other injections.
- GLP-1 medicines for weight loss and diabetes: what you need to know ↗
Confirmed pregnancy, contraception, surgery, use of genuine products, and the latest serious adverse reactions from the patient's perspective.
- Semaglutide: a medicine to manage type 2 diabetes or treat obesity ↗
Referenced the method of placing product verification, usage instructions, missed doses, and common or serious symptoms close to the corresponding actions.
- FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products ↗
Used to explain the risk of overdose due to confusion over concentrations and units, or the use of non-standard vials.